7 units semaglutide (Ozempic)7mg RCSB PDB - 7KI0: Semaglutide-bound

Semaglutide is the active pharmaceutical ingredient in Wegovy (FDA-approved for chronic weight management) and Ozempic (FDA-approved for type 2 diabetes)

Do not exceed 6 sprays per day unless directed by a professional

Biomarkers and Genetic Factors Behind Incretin-Pathway Response Response to incretin-pathway compounds tracks with metabolic biomarkers such as fasting glucose, HbA1c, insulin resistance (HOMA-IR), lipids, and CRP

Novo Nordisk, the maker of semaglutide, sponsored both clinical trials

Once at your destination, inject at a comfortable time in the new time zone and maintain that schedule for the duration of the trip Return adjustment